{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:02:31Z","timestamp":1773378151410,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The relationship between the body mass index (BMI) at the time of breast cancer diagnosis and the prognosis of breast cancer patients has not yet been clarified. We investigated the impact of obesity for clinical outcomes in Japanese breast cancer patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Women with primary breast cancer operated between 2002 and 2014 were identified. All patients are categorized into four groups according to BMI. The range of BMI is &amp;lt;18.5\u00a0kg\/m2, from 18.5 to 24.9\u00a0kg\/m2, 25 to 29.9\u00a0kg\/m2, &amp;gt;30\u00a0kg\/m2 in underweight, normal, overweight and obesity groups, respectively. The correlation between BMI and overall survival (OS), breast cancer-specific survival (BCSS) and disease-free survival (DFS) were statistically analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From the database of our institution, we identified 3223 patients. The median follow-up period was 57\u00a0months (1\u2013149). We categorized 2257 (70.0%), 318 (9.9%), 545 (16.9%) and 103 (3.2%) patients into normal, underweight, overweight obesity groups respectively. There were189 patients (5.9%) deaths due to breast cancer recurrence (137 patients) and other disease (52 patients). Obesity groups was significantly high compared with normal groups for OS (adjusted HR, 2.43; 95% CI, 1.38\u20134.28; P\u00a0&amp;lt;\u00a00.001), BCSS (adjusted HR, 2.73; 95% CI, 1.15\u20136.44; P\u00a0=\u00a00.02) and DFS (adjusted HR, 1.83; 95% CI, 1.11\u20133.02; P\u00a0=\u00a00.017) by multivariate analysis. Especially, OS (adjusted HR, 4.87; 95% CI, 2.15\u201311.04; P\u00a0&amp;lt;\u00a00.001), BCSS (adjusted HR, 4.51; 95% CI, 1.52\u201313.34; P\u00a0&amp;lt;\u00a00.001) and DFS (adjusted HR, 4.87; 95% CI, 1.02\u20134.89; P\u00a0=\u00a00.04) were statistically insignificant in postmenopausal ER-positive breast cancer patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Obesity might be risk factor for OS, BCSS and DFS, especially postmenopausal ER-positive women.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jjco\/hyz175","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T11:10:58Z","timestamp":1572001858000},"page":"230-240","source":"Crossref","is-referenced-by-count":9,"title":["Impact of BMI for clinical outcomes in Japanese breast cancer patients"],"prefix":"10.1093","volume":"50","author":[{"given":"Naomi","family":"Gondo","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Sawaki","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Hattori","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyo","family":"Yoshimura","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruru","family":"Kotani","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Adachi","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Kataoka","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Sugino","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Mori","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanae","family":"Horisawa","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Terada","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ozaki","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroji","family":"Iwata","sequence":"first","affiliation":[{"name":"Department of Breast Oncology, Aichi Cancer Center, Aichi, Japan, 1-1, Kanokoden, Chikusa-ku, Nagoya-city, Aichi 464-8681, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"2020030903371849500_ref1","article-title":"Fact Sheet on obesity and overweight","author":"World Health Organization"},{"key":"2020030903371849500_ref2","article-title":"Obesity update","author":"OECD","year":"2014"},{"key":"2020030903371849500_ref3","article-title":"Body mass index update","author":"Ministry of Health, Labor and Welfare","year":"2014"},{"key":"2020030903371849500_ref4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the million women study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ."},{"key":"2020030903371849500_ref5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1023\/A:1020239211145","article-title":"Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States)","volume":"13","author":"Morimoto","year":"2002","journal-title":"Cancer Causes Control."},{"key":"2020030903371849500_ref6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1207\/S15327914NC4402_02","article-title":"A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer","volume":"44","author":"Connolly","year":"2002","journal-title":"Nutr Cancer."},{"key":"2020030903371849500_ref7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-009-0512-0","article-title":"The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial","volume":"119","author":"de Azambuja","year":"2010","journal-title":"Breast Cancer Res Treat."},{"key":"2020030903371849500_ref8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejca.2013.11.013","article-title":"Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials","volume":"50","author":"Ladoire","year":"2014","journal-title":"Eur J Cancer."},{"key":"2020030903371849500_ref9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10549-012-2073-x","article-title":"Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis","volume":"134","author":"Niraula","year":"2012","journal-title":"Breast Cancer Res Treat."},{"key":"2020030903371849500_ref10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010062","article-title":"Obesity, Leptin and breast cancer: Epidemiological evidence and proposed mechanisms","volume":"11","author":"Ando","year":"2019","journal-title":"Cancers (Basel)."},{"key":"2020030903371849500_ref11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1467-789X.2009.00592.x","article-title":"Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives","volume":"10","author":"Maccio","year":"2009","journal-title":"Obes Rev."},{"key":"2020030903371849500_ref12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/ENDO:18:2:179","article-title":"Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue","volume":"18","author":"Machinal-Quelin","year":"2002","journal-title":"Endocrine."},{"key":"2020030903371849500_ref13","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ijc.21543","article-title":"High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels","volume":"118","author":"Miyoshi","year":"2006","journal-title":"Int J Cancer."},{"key":"2020030903371849500_ref14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00109-010-0611-8","article-title":"Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: Preliminary results and therapeutic implications","volume":"88","author":"Maccio","year":"2010","journal-title":"J Mol Med (Berl)."},{"key":"2020030903371849500_ref15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2007.14.7132","article-title":"Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?","volume":"26","author":"Goodwin","year":"2008","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10911-013-9299-z","article-title":"The obesity-inflammation-eicosanoid axis in breast cancer","volume":"18","author":"Vona-Davis","year":"2013","journal-title":"J Mammary Gland Biol Neoplasia."},{"key":"2020030903371849500_ref17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10549-016-3770-7","article-title":"Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese breast cancer registry","volume":"156","author":"Iwamoto","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"2020030903371849500_ref18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1634\/theoncologist.2017-0148","article-title":"Distinct effects of body mass index and waist\/hip ratio on risk of breast cancer by joint Estrogen and Progestogen receptor status: results from a case-control study in northern and eastern China and implications for chemoprevention","volume":"22","author":"Wang","year":"2017","journal-title":"Oncologist."},{"key":"2020030903371849500_ref19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-2407-12-149","article-title":"Body mass index and survival after breast cancer diagnosis in Japanese women","volume":"12","author":"Kawai","year":"2012","journal-title":"BMC Cancer."},{"key":"2020030903371849500_ref20","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1200\/JCO.2009.22.4436","article-title":"Underweight and breast cancer recurrence and death: a report from the Korean breast cancer society","volume":"27","author":"Moon","year":"2009","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref21","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999-2008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA."},{"key":"2020030903371849500_ref23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1467-789X.2003.00108.x","article-title":"Central obesity and breast cancer risk: a systematic review","volume":"4","author":"Harvie","year":"2003","journal-title":"Obes Rev."},{"key":"2020030903371849500_ref24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3346\/jkms.2001.16.5.610","article-title":"Is body mass index the prognostic factor in breast cancer?: a meta-analysis","volume":"16","author":"Ryu","year":"2001","journal-title":"J Korean Med Sci."},{"key":"2020030903371849500_ref25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","article-title":"Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis","volume":"123","author":"Protani","year":"2010","journal-title":"Breast Cancer Res Treat."},{"key":"2020030903371849500_ref26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","article-title":"Effect of obesity on prognosis after early-stage breast cancer","volume":"29","author":"Ewertz","year":"2011","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref27","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","article-title":"Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial","volume":"28","author":"Sestak","year":"2010","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref28","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1200\/JCO.2011.40.8666","article-title":"Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial","volume":"30","author":"Ewertz","year":"2012","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref29","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.7314\/APJCP.2013.14.4.2225","article-title":"Effects of obesity on presentation of breast cancer, lymph node metastasis and patient survival: a retrospective review","volume":"14","author":"Kaviani","year":"2013","journal-title":"Asian Pac J Cancer Prev."},{"key":"2020030903371849500_ref30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T","article-title":"Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma","volume":"92","author":"Daling","year":"2001","journal-title":"Cancer."},{"key":"2020030903371849500_ref31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jnci\/dji249","article-title":"Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance","volume":"97","author":"Arpino","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"2020030903371849500_ref32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10549-005-9118-3","article-title":"Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer","volume":"97","author":"Dignam","year":"2006","journal-title":"Breast Cancer Res Treat."},{"key":"2020030903371849500_ref33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3332\/ecancer.2018.821","article-title":"Obesity and outcome of post-menopausal women receiving adjuvant letrozole for breast cancer","volume":"12","author":"Zekri","year":"2018","journal-title":"Ecancermedicalscience."},{"key":"2020030903371849500_ref34","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1200\/JCO.2007.13.9279","article-title":"Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer","volume":"26","author":"Dixon","year":"2008","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaci.2005.04.036","article-title":"Mechanisms of nutrient modulation of the immune response","volume":"115","author":"Cunningham-Rundles","year":"2005","journal-title":"J Allergy Clin Immunol."},{"key":"2020030903371849500_ref36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/hmbci-2015-0011","article-title":"Vitamin D3 in cancer prevention and therapy: the nutritional issue","volume":"23","author":"Chirumbolo","year":"2015","journal-title":"Horm Mol Biol Clin Investig."},{"key":"2020030903371849500_ref37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol."},{"key":"2020030903371849500_ref38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11684-018-0652-x","article-title":"Paradoxical role of id proteins in regulating tumorigenic potential of lymphoid cells","volume":"12","author":"Roy","year":"2018","journal-title":"Front Med."},{"key":"2020030903371849500_ref39","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2001.19.9.2381","article-title":"Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy","volume":"19","author":"Demark-Wahnefried","year":"2001","journal-title":"J Clin Oncol."},{"key":"2020030903371849500_ref40","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/jama.293.20.2479","article-title":"Physical activity and survival after breast cancer diagnosis","volume":"293","author":"Holmes","year":"2005","journal-title":"JAMA."}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/50\/3\/230\/32854160\/hyz175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/50\/3\/230\/32854160\/hyz175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T18:43:19Z","timestamp":1721932999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/50\/3\/230\/5709798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,1,20]]},"published-print":{"date-parts":[[2020,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyz175","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,1,20]]}}}